Transplanting Lungs From Uncontrolled Donation After Circulatory Death
- Conditions
- Lung Transplantation
- Interventions
- Device: Lung uDCD Protocol
- Registration Number
- NCT06327945
- Lead Sponsor
- NYU Langone Health
- Brief Summary
The study team developed an uncontrolled donation after circulatory death (uDCD) protocol that preserves lungs for just over 3 hours after death using positive end expiratory pressure (PEEP) and supplemental oxygen. The study will assess lung uDCD program safety by continuous review of operations/clinical records from each case activation and transplantation. Attrition outcomes include rates of initial and continued lung preservation, donation authorization, lung recovery, passing ex-vivo lung perfusion (EVLP) performance testing, and lung transplantation. Planned viability assessments also include macroscopic determination, radiology (X-ray), and fiber optic bronchoscopy before initiating EVLP. We expect \~50% of lungs assessed with EVLP will be transplanted to meet sustainability targets. Safety outcomes include the primary outcome, primary graft dysfunction (PGD) grade III at 72 hours, and secondarily survival one year after transplantation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 24
- Patients waiting for lung transplants
- Willing to participate in the research study
- Unable to be followed for 1 year after transplantation
- Unable to provide written informed consent to participate in the research (or designate a surrogate)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Lung uDCD Protocol Lung uDCD Protocol -
- Primary Outcome Measures
Name Time Method Incidence of Primary Graft Dysfunction (PDG) Grade III 72 Hours Post-Transplant PGD is measured 72 hours after transplantation and defined according to the International Society for Heart and Lung Transplantation (ISHLT) criteria: partial pressure of arterial oxygen divided by the fraction of inspired oxygen (Pa02/FI02) \< 200 mm Hg.
- Secondary Outcome Measures
Name Time Method Number of Participants who Required Normothermic Extracorporeal Membrane Oxygenation (nECMO) 1 Year Post-Transplant Incidence of Re-Transplantation 1 Year Post-Transplant Overall Survival 1 Year Post-Transplant Time from transplant to death due to any cause.
Trial Locations
- Locations (1)
NYU Langone Health
🇺🇸New York, New York, United States